About International Conference on Cardiology and Cardiovascular Diseases

International Conference on Cardiology and Cardiovascular Diseases presents a unique occasion to meet prominent surgeons, Oncologists, Radiologists, Chemotherapists, Physicians, Academicians, Academic scientists, Industry professionals, Diagnostic laboratory professionals, Post-Graduate students, Post-doctoral fellows, and Trainees across the globe and listen to best speakers on new expansions that will influence and spread the future of Cardiology. This is your single best opportunity to reach the largest assemblage of participants .World-renowned speakers, the most recent techniques, and the newest updates in cardiology research fields are hallmarks of this conference.

Cardiology and Cardiovascular Diseases Highlights:

Cardiology Conference is meant to gather leading intellects to a platform for round table discussion on cardiac effects and Cardiovascular Diseases and its progress. It is the unique aid to convey globally renowned universities in the department of cardiac field, bring together world-class cardiologists, scientists and professors to discuss strategies for disease remediation for heart in this cardiology conference. This is the congress where you will be having an outstanding experience with the gathering. This conference will provide a comprehensive update on all medical, surgical, interventional, and electrophysiological topics in cardiology and also you can improve your network globally by interacting with the various experts related to the field of Cardiology across the world.

Dr. Guy Hugues Fontaine
Universite Pierre et Marie Curie
France

Dear Colleagues & Scientists,

I have the privilege to welcome you to International Conference on Cardiology & Cardiovascular Diseases going to be held during July 10-12, 2017 in Flora Creek Hotel, Dubai, UAE to discuss this important aspect of Medicine which is the Prevention of CV diseases. This the cause of death in 50% of the population and a major cause of expenditure in the advanced countries of the western world.

The cause of CV diseases is multifactorial congenital, hereditary and acquired with two subgroups such as myocarditis which can be superimposed on cardiomyopathies or the result of environmental factors which is the cause of the most frequent consequence: myocardial infarction and stroke. The prevention of these CV diseases is basically simple but extremely difficult to control in practice because reduction of food intake and regular daily exercise are not easily accepted.

Being a French cardiologist I will address some interesting remarks stressing the value of wine and especially red wine to prevent CV diseases but also other diseases. It is known that alcohol is good for the heart whatever its presentation, beer, wine, cocktails and spirits. However, the red wine is the best because it contains tannin (which gives the colour of red wine). This tannin contains a molecule called "Resveratrol" which has interesting properties:

1. Heart for primary protection against myocardial events such as myocardial infarction
2. Prevention of Alzheimer disease
3. And also, more recently, its increase in neurogenesis

However, all the studies have demonstrated an increased risk of developing different types of cancer even for small drinkers.

Finally control food intake, exercise and moderate consumption of red wine rich in tannin looks a good compromise for primary prevention of cardiovascular events.

Hope to meet you at Cardiology 2017 conference in Dubai, UAE


Dr. Osman El-Labban
Family Medicine Consultant
Al Zahra Hospital Dubai,UAE



Dear Colleagues & Scientists,

I have the privilege to welcome you to International Conference on Cardiology & Cardiovascular Diseases going to be held during July 10-12, 2017 in Flora Creek Hotel, Dubai, UAE to discuss about Cardiovascular diseases (CVD) represent the major causes of disability and premature death all over the world contributing to the escalating costs of health care sector. With CVD moving the phase of being predominantly acute diseases to be more chronic diseases and consequently having high proportion of senior population, one can expect that the number of years of any senior patients spent with heart diseases morbidity will increase. Also, there is demand to preserve a high quality of life for CVD patients.

The conference will consist of keynote speeches, invited lectures, technical sessions and workshop, all focusing on the scientific frontiers in the pharmacology and pharmacy of drugs.

The underlying pathology in CVD is atherosclerosis which begins early in life and progresses gradually through adolescence and early adulthood.The rate of progression of atherosclerosis is influenced by CV risk factors including tobacco use, an unhealthy diet and physical inactivity, hypertension, dyslipidaemia & diabetes. Not only this, but the probability of developing CVD increases exponentially with the aggregation of conventional risk factors.

A significant proportion of CVD morbidity and mortality can be prevented through reversing the epidemic of heart disease by adoption of an effective prevention program through either population-based strategies which address changes in lifestyle of everyone in the population or through screening of high risk patients where early detection of these "risky" individuals is of paramount importance to prevent progression of CVD and hence reduce the incidence of newly diagnosed cases.

It is our commitment in the conference to raise awareness on the importance of prevention programs amongst healthcare professionals with emphasis on proper diagnosis which should be timely and accurate, on providing treatment that is should be appropriate to each patient and on long-term management which should include follow-up, monitoring and support.

Hope to meet you at Cardiology 2017 conference in Dubai, UAE


Samer Ellahham
Sr Cardiovascular Consultant
Sheikh Khalifa Medical City (SKMC)
UAE

OSMAN El-LABBAN
Department of Family Medicine
Al Zahra Hospital
UAE

Stamatios Lerakis
Department of Medicine
Emory University
USA

Hadi Khafaji
Department of Cardiology
Toronto University
Canada

Ali Mahmoud Ahmed Kassem
Department of Medicine
Sohag University
Egypt

Dr. M. Nazrul Islam
Department of Cardiology
Bangabandhu Sheikh Mujib Medical University, Dhaka

Sharaf El Deen Shazly Abdalla
Department of Medicine
Sohag University
Egypt

NAZARIO CARRABBA
Department of Cardiology
Careggi Hospital
Italy

Michael Brainin
Dept of Clinical Neuroscience
Danube University
Austria

M. Mostafa Zaman
Department of Epidemiology
World Health Organization
Bangladesh

Rajib Ghosh
Department of Cardiology
National Institute of cardiovascular Diseases, Bangladesh

Mithun Das
Department of Anthropology
Sree Chaitanya College
India

The speciality of cardiology developed as a sub specialization of physicians who are predominantly concerned with care of patients of cardiovascular disorders. It is a branch of internal medicine concerned with prevention, investigation and therapy of, and research into,diseases involving the cardiovascular system. Cardiovascular disease (CVD) is the leading cause of death in the U.S. Cardiovascular disease (CVD) affects the lives of millions of people and is one of the largest causes of death and disability in this country. Huge improvements have been made in the prevention and treatment of CVD.

Technical Sessions
Advances in Cardiology Education
Current Research in Cardiology
Pediatric Cardiology
Cardiac Diagnostic & Tests
Women and Cardiac Arrhythmia
Cardiomyopathy & Heart Failure
Heart Devices or Defibrillators
Cardiac Rhythm Abnormalities
Cardiovascular Toxicity and Cancer Treatments
Cardiovascular Pathology
Cardiovascular Alternative Medicine
Cardiac Regeneration and Repair
Cardiovascular Case Studies
Pregnancy Hypertension
Cardiovascular Industries Market Research
Nutrition, Metabolism and cardiovascular Diseases
This browser does not support PDFs. Please download the PDF to view it: Download PDF.